Column Group

Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Surrozen, ORIC, TNYA, Rapt Therapeutics, RVMD, and represent 100.00% of Column Group's stock portfolio.
  • Added to shares of these 1 stock: Surrozen (+$7.9M).
  • Reduced shares in these 1 stock: Rapt Therapeutics.
  • Column Group was a net buyer of stock by $7.6M.
  • Column Group has $83M in assets under management (AUM), dropping by 2.27%.
  • Central Index Key (CIK): 0001833486

Tip: Access up to 7 years of quarterly data

Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Column Group

Column Group holds 5 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Surrozen 50.5 $42M +23% 1.9M 22.60
 View chart
Oric Pharmaceuticals (ORIC) 35.0 $29M 3.5M 8.18
 View chart
Tenaya Therapeutics (TNYA) 8.1 $6.7M 9.4M 0.71
 View chart
Rapt Therapeutics 6.4 $5.3M -5% 156k 33.87
 View chart
Revolution Medicines (RVMD) 0.0 $3.7k 46.00 79.65
 View chart

Past Filings by Column Group

SEC 13F filings are viewable for Column Group going back to 2020

View all past filings